logo-dark.png
UPDATE -- Aegis Sciences Corporation announces participation in National Testing Action Plan for K-12 Schools to Safely Reopen
April 07, 2021 16:13 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., April 07, 2021 (GLOBE NEWSWIRE) -- The Rockefeller Foundation announced an initiative on March 26, to provide guidance on testing for K-12 public schools to enable safe in-person...
logo-dark.png
Aegis Sciences Corporation announces participation in National Testing Action Plan for K-12 Schools to Safely Reopen
April 07, 2021 12:19 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., April 07, 2021 (GLOBE NEWSWIRE) -- The Rockefeller Foundation announced an initiative on March 26, to provide guidance on testing for K-12 public schools to enable safe in-person...
logo-dark.png
Aegis Sciences Announces CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19
March 16, 2021 09:00 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., March 16, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services,...
logo-dark.png
Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing
February 11, 2021 08:00 ET | Aegis Sciences Corporation
NASHVILLE, Tenn. and DEERFIELD, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...
logo-dark.png
Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus
November 16, 2020 11:20 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
logo-dark.png
Oral Fluid Testing Capabilities Expanded to Identify Pertinent Drug Interactions
November 09, 2020 11:00 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting...
logo-dark.png
Aegis Sciences Corporation announces it has been awarded $6.6 million NIH grant to rapidly expand COVID-19 Test Capacity
September 02, 2020 11:05 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting...
logo-dark.png
Aegis Sciences Corporation Announces National Launch of COVID-19 Antibody Testing Utilizing Convenient Dry Blood Spot Technology
August 31, 2020 10:30 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
logo-dark.png
Aegis Sciences Corporation Announces National Launch of Expanded Novel Psychoactive Substance Testing
July 27, 2020 12:10 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
logo-dark.png
Aegis Sciences Corporation Testing for Coronavirus Disease 2019 (COVID-19) Now Authorized to Report in all 50 states
June 09, 2020 12:11 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., June 09, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...